Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan TM

Clinical and Experimental Rheumatology

Volumn 27, Issue 2, 2009, Pages 253-259

  Matteson, E L ^a,d   Lowe, V J ^b   Prendergast, F G ^c   Crowson, C S ^d   Moder, K G ^a   Morgenstern, D E ^e   Messmann, R A ^e   Low, P S ^f  

^a Division of Rheumatology   (Spain)

^b Division of Radiology

^c Center for Individualized Medicine   (Germany)

^d Mayo Clinic College of Medicine   (United States)

^e Endocyte Inc   (United States)

^f PURDUE UNIVERSITY   (United States)

Author keywords

Folate receptor; FolateScan; Radiopharmaceutical; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; EC20; FOLATESCAN; FOLIC ACID; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; ARTHROPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HONEYBEE; HUMAN; INFLAMMATORY DISEASE; INJECTION SITE CONTUSION; JOINT SWELLING; MALE; OSTEOARTHRITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGIST; RHEUMATOID ARTHRITIS; TARGET ORGAN;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; SODIUM PERTECHNETATE TC 99M;

EID: 67249164181     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. KINNE RW. BRAUER R. STUHLMULLFR B. PALOMBO-KINNE E. BURMESTER GR: Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2: 189-202.
2. YANNI G. WHELAN A. FEIGHERY C. BRESNIHAN B: Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994: 53: 39-44
3. TAK PP. SMEETS Ti. DAHA RR et al.: Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997; 40: 217-25.
4. MULHERIN D, FITZGERALD O, BRESNIHAN B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheutn 1996; 39: 15-124.
5. BRESNIHAN B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatot 1999; 26: 717-9.
6. TURK MJ, BREUR Gi, WIDMER WR et at.: Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Rheum 2002; 46: 1947-55.
7. NAKASHIMA-MATSUSHITA N, HOMMA T, YU S: Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 1609-16.
8. PAULOS CM, TURK MJ, BREUR GJ. LOW PS: Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 2004; 29:1205-17.
9. TURK MJ, WATERS DJ, LOW PS: Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Leti 2004; 213: 165-72.
10. SHEN F, ROSS JF, WANG X, RATNAM M: Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: eDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 1994; 33: 1209-15.
11. GARIN-CHESA P. CAMPBELL I, SAIGO PE, LEWIS JL JR, OLD U, RETTIG Wi: Trophoblast and ovarian cancer antigen LK26: sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathology 1993; 142: 557-67.
12. ROSS JF, CHAUDHURI PK, RATNAM M: Differential regulation of folate receptor iso- forms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994; 73: 2432-43.
13. MANTOVANI LT, MIOTII S, MÉNARD S et at.: Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies Movl8 and Movl9. Eur J Cancer 1994; 3: 363-9.
14. MATTES M.J, MAJOR PP, GOLDENBERG DM, DION AS, HUTFER RVP. KLEIN KM: Patterns of antigen distribution in human carcinomas. Cancer Research Suppl 1990; 50: 880S.
15. WEITMAN SD, LARK RH, CONEY UR et at.: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Research 1992; 52: 3396-401.
16. SIEGEL BA, DEI-IDASHTI F, MUTCH DC et at.: Evaluation of 11 lIn-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nuct Med 2003; 44: 700-7.
17. HILGENBRINK AR, LOW PS: Folate receptor- mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 2005; 94: 2135-46.
18. LOW PS, HENNE WA, DOORNEWEER DD: Discovery and development of folic-acidbased receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008; in press.
19. LEAMON CP, PARKER MA, VLAHOV IR et at.: Synthesis and biological evaluation of EC2O: a new folate-derived,99mTc-based radiopharmaceutical. Bioconjugate Chem 2002; 13: 1200-10.
20. REDDY JA, XU LC, PARKER N, VETZEL M, LEAMON CP: Preclinical evaluation of (99m)Tc-EC2O for imaging folate receptor-positive tumors. J Nucl Med 2004; 45: 857-66.
21. WANG S, LUO J, LANTRIP DA et at.: Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem 1997; 8: 673-9.
22. FISHER RE, SIEGEL BA, EDELL SL et al.: Exploratory study of 99mTc-EC2O imaging for identifying patients with folate receptor- positive solid tumors. J Nuct Med 2008; 49: 899-906
23. CHEN WT, MAHMOOD U, WEISSLEDER R, TUNG CH: Arthritis imaging using a near- infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005; 7: R310-17.
24. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
25. PREVOO ML, VAN'T HOE MA, KUPER RH, VAN LEEUWEN MA. VAN DE PUTTE LB. VAN RIEL PL: Modified disease activity scores that include twenty-eight joint counts. Arthritis Rheum 1995; 38: 44-8.
26. SCOTT DL, ANTONI C, CHOY EH, VAN RIEL PCLM: Joint counts in routine practice. Rheumatology 2003; 42: 9 19-23.
27. EFRON B: The jackknife, the bootstrap and other resampting plans, Regional Conference Series in Applied Mathematics, 38. SIAM, Philadelphia, 1982.
28. PAULOS CM. VARGHESE B, WIDMER R, BREUR, Gi, VLASHI E, LOW PS: Folatetargeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther 2006; 8: R77.
29. McQUEEN F, STEWART N, CRABBE J et al.: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999; 58: 156-63.
30. DUREZ P. MALGHEM J, TOUKAP AN et at.: Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum 2007; 56: 39 19-327.